SAN CLEMENTE, Calif., June 21, 2012 /PRNewswire/ -- ReShape Medical, a company focused on a non-surgical weight loss device, announced today that Robert E. Grant will join its board of directors.
Grant currently serves as chairman of Strathspey Crown LLC, a growth equity firm in Newport Beach focusing on lifestyle healthcare and cash-pay medical products. He is former president of the medical aesthetics division at Allergan Inc. in Irvine and most recently served as chief executive officer and president of Bausch+Lomb Surgical in Aliso Viejo. He brings extensive experience leading global medical device and pharmaceutical organizations.
"Robert is a visionary leader and strategist and we are delighted that he is joining the team," said Richard Thompson, ReShape Medical president and CEO. "His expertise with cash-pay, elective medical procedures will be invaluable as we move toward commercialization." ReShape Medical is preparing to begin a pivotal clinical study to gain approval in the U.S. and launched commercially in Europe earlier this year.
Grant said, "I strongly believe there is a huge market opportunity for non-surgical weight loss devices and also that ReShape Medical is well positioned to be the market leader. I am honored to be joining the talented and experienced ReShape board."
In addition to Grant, ReShape Medical's board of directors consists of: Ken Charhut (Chairman), President and CEO of Mindframe Inc.; Jeani Delagardelle, Managing Director of New Leaf Venture Partners; Casey Tansey, General Partner at US Venture Partners; David Milne, Managing Partner at SV Life Sciences; George Wallace, Managing General Partner for Intersect Partners LLC; and Richard Thompson, President and CEO of ReShape Medical.
About ReShape Medical, Inc.
ReShape Medical® is a medical device manufacturer headquartered in Southern California. The company specializes in a dual-intragastric balloon for weight loss, ReShape Duo®, to be used as an aid in the treatment of obese or overweight patients. ReShape Duo is a non-surgical alternative designed for those who have exhausted their efforts with diet alone and wish to avoid or do not qualify for surgery. It comfortably occupies existing space in the stomach for six months, serving as built in portion control, to help patients feel full and satisfied with less food. CAUTION - Limited by United States law to investigational use.
|SOURCE ReShape Medical, Inc.|
Copyright©2012 PR Newswire.
All rights reserved